VirtualScopics Receives Additional Time to Regain Compliance with Nasdaq

   VirtualScopics Receives Additional Time to Regain Compliance with Nasdaq

PR Newswire

ROCHESTER, N.Y., Feb. 28, 2013

ROCHESTER, N.Y., Feb. 28, 2013 /PRNewswire/ --VirtualScopics, Inc. (Nasdaq:
VSCP) today announced that The Nasdaq Stock Market has informed the Company
that it has been granted an additional 180 day period, or until August26,
2013, to regain compliance with the minimum $1 bid price per share
requirement. The determination was based on the Company meeting the continued
listing requirement for market value of publicly held shares and all other
applicable requirements for initial listing on Nasdaq with the exception of
the bid price requirement, and the Company's intent to cure the deficiency
during the second compliance period by effecting a reverse stock split, if

If at any time during this additional time period the closing bid price of the
Company's stock is at least $1 per share for a minimum of 10 consecutive
business days, Nasdaq will provide written confirmation of compliance and the
matter will be closed.

About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate
drug and medical device development. VirtualScopics has developed a robust
software platform for analysis and modeling of both structural and functional
medical images. In combination with VirtualScopics' industry-leading
experience and expertise in advanced imaging biomarker measurement, this
platform provides a uniquely clear window into the biological activity of
drugs and devices in clinical trial patients, allowing sponsors to make better
decisions faster. For more information about VirtualScopics, visit

Forward-Looking Statements
The statements contained in this press release that are not purely historical
are forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended and Section 21E of the Securities Exchange
Act of 1934, as amended, and are intended to be covered by the safe harbors
created thereby. These forward-looking statements include, but are not limited
to, statements regarding the Company's attempts to regain compliance with
Nasdaq listing requirements, the expected benefits of the Company's investment
in infrastructure and new customer contract signings and awards and/or
statements preceded by, followed by or that include the words "believes,"
"could," "expects," "anticipates," "estimates," "intends," "plans,"
"projects," "seeks," or similar expressions. Forward-looking statements deal
with the Company's current plans, intentions, beliefs and expectations.
Investors are cautioned that all forward-looking statements involve risks and
uncertainties that could cause actual results to differ materially from those
in the forward-looking statements. Many of these risks and uncertainties are
discussed in the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 2011 filed with the Securities and Exchange Commission (the
"SEC"), and in any subsequent reports filed with the SEC, all of which are
available at the SEC's website at These include without
limitation: the risk of cancellation or delay of customer contracts or
specifically as it relates to contact awards, the risk that they may not get
signed. Other risks include the company's dependence on its largest customers
and risks of contract performance, protection of our intellectual property and
the risks of infringement of the intellectual property rights of others. All
forward-looking statements speak only as of the date of this press release and
the Company undertakes no obligation to update such forward-looking

CONTACTS: Investor Relations:        Company Contact:
             Tim Ryan                   Molly Henderson
             The Shoreham Group        Chief Business and Financial Officer,
                                        Sr. Vice President
             80 Eighth Ave, Ste 1107    500 Linden Oaks
             New York, NY 10011         Rochester, New York 14625
             +1 212 242 7777 Direct  +1 585 249.6231

SOURCE VirtualScopics, Inc.

Press spacebar to pause and continue. Press esc to stop.